Clinical Trials Directory

Trials / Unknown

UnknownNCT01075022

Effect of a Single Colecalciferol Dose on Insulin Resistance

Effect of a Single Colecalciferol Dose on Insulin Resistance: A Prospective Randomized Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
136 (estimated)
Sponsor
Hospital de Clinicas de Porto Alegre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A Prospective Double-Blinded, Placebo Controlled, Randomized Trial comparing a single dose of Vitamin D (Colecalciferol) 300.00UI to placebo on patients with insulin resistance. Primary Outcome: Blood glucose and homeostasis model assessment for insulin resistance (HOMA-R) after 90 days. Study hypothesis: Vitamin D treatment may improve insulin resistance and decrease glucose level, since there is an association between hypovitaminosis D and increased insulin resistance.

Conditions

Interventions

TypeNameDescription
DRUGColecalciferol (Vitamin D3) 300.000 UIColecalciferol (Vitamin D3) 300.000 UI Capsule, Single Dose
DRUGPlaceboPlacebo Capsule, Single Dose

Timeline

Start date
2009-05-01
Primary completion
2010-07-01
Completion
2010-07-01
First posted
2010-02-24
Last updated
2010-02-24

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01075022. Inclusion in this directory is not an endorsement.